September 19, 2019

Use of Further Opioid Sales for Settlement Payments: Blood Money or Common Practice?

According to the Associated Press, a number of states have rejected the settlement made with Purdue Pharma. Under the settlement, future sales and profits from opioids would go towards settlement payments, and many are calling this “blood money.” Under the agreement, the Sackler family, owners of Purdue Pharma, must relinquish ownership, with the company being reconstituted as a public benefit trust. Advocates fear this may not be enough to make an impact, while others believe this is required, as the lack of regulation of the use of the drug and the money is going to have to come from somewhere.